Alembic Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Telmisartan Tablets, USP, 20 mg Due to Label Mix-Up


Bridgewater, NJ, Alembic Pharmaceuticals, Inc is voluntarily recalling one lot of Telmisartan Tablets, USP, 20 mg, packaged in 30-count bottles, Lot No. 1905005661 to the consumer level. The product is being recalled due to a market complaint received which stated that one bottle labelled as 30-cou (US Food Recalls) More More

Similar stories

Antihypertensive Medication Recalled Due to Label Mix-Up - Monthly Prescribing Reference

Antihypertensive Medication Recalled Due to Label Mix-Up  Monthly Prescribing Reference

Posted on 30 March 2021 | 2:00 am | Google News

Alembic Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Telmisartan Tablets, USP, 20 mg Due to Label Mix-Up - FDA.gov

Alembic Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Telmisartan Tablets, USP, 20 mg Due to Label Mix-Up  FDA.gov

Posted on 24 March 2021 | 2:00 am | Google News

Lupin recalls around 5.61 lakh pouches of birth control pills in the US market - ETHealthworld.com

Lupin recalls around 5.61 lakh pouches of birth control pills in the US market  ETHealthworld.com

Posted on 21 August 2020 | 8:13 am | Google News

Unichem, Macleods Pharma recall drugs from US market - ETHealthworld.com

Unichem, Macleods Pharma recall drugs from US market  ETHealthworld.com

Posted on 16 February 2020 | 4:40 am | Google News

Lupin recalls over 12K cartons of birth control tablets from US market - ETHealthworld.com

Lupin recalls over 12K cartons of birth control tablets from US market  ETHealthworld.com

Posted on 7 April 2019 | 4:11 am | Google News

Three Made in India drugs recalled in US: FDA - ETHealthworld.com

Three Made in India drugs recalled in US: FDA  ETHealthworld.com

Posted on 16 October 2017 | 6:43 pm | Google News

Copyright © 2021 LastMinuteStuff.com | Contact info